Address: Chegongzhuang Street, Xicheng District, Beijing, No. 6, Building 3, Room 404,
Postal Code: 100044
Tel: -68004287
Web: http://www.cpema.org/home/
Chinese association bringing together pharmaceutical companies in order to participate in debates and make policy recommendations regarding the pharmaceutical industry.
Policy
The latest news from Chinese pharma and biotech, including news that state-owned Sinopharm is now developing its…
Song Ruilin, chairman of the China Pharmaceutical Innovation and Research Development Association (PhIRDA), picks…
The following is an overview from Accestra Consulting* of Part 1 of China’s Center for Drug Evaluation (CDE)’s…
The latest news from Chinese pharma, including Fosun Pharma’s 2021 interim results; how AstraZeneca, Bayer, Eli…
In a comprehensive new piece, European Patent Attorney André Bourgouin and Adjunct Professor at CEIBS Eric…
In a big career move on a personal level and a sign of China’s continuing significance to global pharma, Hong…
The latest news from the Chinese pharmaceutical industry, including recent deals between domestic pharma giant…
A historic approval for Fosun-Kite’s CAR-T therapy Yescarta in China looks set to pave the way for further…
The latest news from Chinese pharma, including a historic first approval for Fosun Kite’s CAR-T therapy Yescarta;…
MSD, which has had a presence in China since 1990, recently appointed Belgian national Anna van Acker to lead its…
Writing in the June edition of DIA’s Global Forum magazine, Harbour BioMed’s Fang Zhou, in conversation…
With three years having passed since the Hong Kong Stock Exchange (HKEX)’s decision to allow pre-revenue biotechs…
